It is very uncertain whether single‐dose changes recurrence compared with short‐course (3‐7 days) antibiotics (very low certainty).
It is very uncertain whether single‐dose changes re‐infection compared with short‐course (3‐7 days) antibiotics (very low certainty).
It is very uncertain whether single‐dose changes persistent bacteriuria compared with conventional 10‐day antibiotic treatment (very low certainty).
It is very uncertain whether single‐dose changes persistent symptoms compared with conventional 10‐day antibiotic treatment (very low certainty).
It is very uncertain whether single‐dose changes persistent bacteriuria and symptoms compared with conventional 10‐day antibiotic treatment (very low certainty).
It is very uncertain whether single‐dose changes recurrence compared with conventional 10‐day antibiotic treatment (very low certainty).
Single dose probably leads to higher bacteriuria compared with multiple dose antibiotic (moderate certainty).
Single dose showed no clear difference in fever compared with multiple dose antibiotic (low certainty).
Single dose showed no clear difference in UTI compared with multiple dose antibiotic (moderate certainty).
Single dose showed no clear difference in hospitalization compared with multiple dose antibiotic (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Single‐incision slings showed no clear difference in number of women with mesh exposure, extrusion or erosion in any area compared with retropubic minimally‐invasive slings (low certainty).
Single‐incision slings showed no clear difference in number of women with urinary retention compared with retropubic minimally‐invasive slings (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether single‐incision slings changes number of women requiring repeat continence surgery or mesh revision compared with retropubic minimally‐invasive slings (very low certainty).
Single‐incision slings showed no clear difference in subjective cure or improvement of urinary incontinence: 12 months compared with transobturator minimally‐invasive slings (high certainty).
Single‐incision slings probably leads to lower patient‐reported pain: at more than 24 months compared with transobturator minimally‐invasive slings (moderate certainty).
Single‐incision slings showed no clear difference in number of women with dyspareunia compared with transobturator minimally‐invasive slings (moderate certainty).
Single‐incision slings leads to lower number of women with mesh exposure, extrusion or erosion in any area compared with transobturator minimally‐invasive slings (high certainty).